Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-11-09 Purchase |
2022-11-14 4:30 pm |
BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner |
12,506,250 | $0 | $0 | 62,965,513 (Indirect) |
View |
2022-07-05 Sale |
2022-07-05 6:48 pm |
BIORA THERAPEUTICS INC. | BIOR | Sarna Surbhi Director |
7,517 | $0.61 | $4,585 | 148,774 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-11-15 Tax Withholding |
2022-11-16 9:49 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks |
4,529 | $0.27 | 542,398 (Direct) |
View |
2022-11-15 Tax Withholding |
2022-11-16 9:48 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer |
175,071 | $0.27 | 2,799,858 (Direct) |
View |
2022-11-15 Tax Withholding |
2022-11-16 9:48 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer |
5,194 | $0.27 | 710,122 (Direct) |
View |
2022-11-09 Option Award |
2022-11-14 4:30 pm |
2023-05-09 2028-05-09 |
BIORA THERAPEUTICS INC. | BIOR | Athyrium Opportunities III Co-Invest 1 LP Athyrium Opportunities III Acquisition LP Athyrium Opportunities III Acquisition 2 LP Athyrium Opportunities 2020 LP Ferrell Jeffrey Athyrium Opportunities Associates Co-Invest LLC Athyrium Funds GP Holdings LLC Athyrium Opportunities Associates III LP Athyrium Opportunities Associates III GP LLC 10% Owner |
8,097,166 | $0 | 62,965,513 (Indirect) |
View |
2022-08-15 Tax Withholding |
2022-08-16 6:02 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks |
1,355 | $1.04 | 546,927 (Direct) |
View |
2022-08-15 Tax Withholding |
2022-08-16 5:58 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer |
5,952 | $1.04 | 708,429 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:31 pm |
N/A 2032-06-15 |
BIORA THERAPEUTICS INC. | BIOR | Kotzin Brian L. Director |
244,964 | $0 | 292,482 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:31 pm |
N/A 2032-06-15 |
BIORA THERAPEUTICS INC. | BIOR | Howe Jill Ann Director |
244,964 | $0 | 321,718 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-15 |
BIORA THERAPEUTICS INC. | BIOR | Alter Jeffrey D. Director |
244,964 | $0 | 312,482 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-15 |
BIORA THERAPEUTICS INC. | BIOR | Powell Lynne Director |
244,964 | $0 | 292,482 (Direct) |
View |
2022-06-15 Option Award |
2022-06-17 4:30 pm |
N/A 2032-06-15 |
BIORA THERAPEUTICS INC. | BIOR | Sarna Surbhi Director |
244,964 | $0 | 305,101 (Direct) |
View |
2022-05-15 Tax Withholding |
2022-05-17 5:27 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks |
8,305 | $0.75 | 936,034 (Direct) |
View |
2022-05-15 Option Award |
2022-05-17 5:27 pm |
N/A 2032-05-15 |
BIORA THERAPEUTICS INC. | BIOR | NEUMANN CLARKE See Remarks |
627,714 | $0 | 936,034 (Direct) |
View |
2022-05-15 Option Award |
2022-05-17 5:19 pm |
N/A 2032-05-15 |
BIORA THERAPEUTICS INC. | BIOR | MOHANTY ADITYA P. Chief Executive Officer |
4,057,925 | $0 | 5,470,354 (Direct) |
View |
2022-05-15 Tax Withholding |
2022-05-17 5:18 pm |
N/A N/A |
BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer |
10,387 | $0.75 | 1,177,685 (Direct) |
View |
2022-05-15 Option Award |
2022-05-17 5:18 pm |
N/A 2032-05-15 |
BIORA THERAPEUTICS INC. | BIOR | dEsparbes Eric Chief Financial Officer |
764,901 | $0 | 1,177,685 (Direct) |
View |
2022-04-15 Option Award |
2022-04-19 4:23 pm |
N/A 2032-04-15 |
PROGENITY INC. | PROG | dEsparbes Eric Chief Financial Officer |
606,725 | $0 | 798,203 (Direct) |
View |
2022-04-15 Option Award |
2022-04-19 4:21 pm |
N/A 2032-04-15 |
PROGENITY INC. | PROG | NEUMANN CLARKE See Remarks |
484,040 | $0 | 615,822 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | dEsparbes Eric Chief Financial Officer |
4,919 | $1.9 | 191,478 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | Hashemi Hutan Chief Compliance Officer |
187 | $1.9 | 28,495 (Direct) |
View |
2022-02-15 Tax Withholding |
2022-02-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | NEUMANN CLARKE See Remarks |
1,716 | $1.9 | 131,782 (Direct) |
View |
2021-11-15 Tax Withholding |
2021-11-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | NEUMANN CLARKE See Remarks |
752 | $3.47 | 133,498 (Direct) |
View |
2021-11-15 Tax Withholding |
2021-11-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | Hashemi Hutan Chief Compliance Officer |
645 | $3.47 | 28,682 (Direct) |
View |
2021-11-15 Tax Withholding |
2021-11-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | Cooper Matthew T General Manager, Diagnostics |
700 | $3.47 | 134,039 (Direct) |
View |
2021-11-15 Tax Withholding |
2021-11-17 4:05 pm |
N/A N/A |
PROGENITY INC. | PROG | Silvestry Damon See Remarks |
4,566 | $3.47 | 291,499 (Direct) |
View |
2021-11-08 Option Award |
2021-11-15 7:34 pm |
N/A 2031-11-08 |
PROGENITY INC. | PROG | MOHANTY ADITYA P. Chief Executive Officer |
3,499,327 | $0 | 3,499,327 (Direct) |
View |
2021-11-03 Option Award |
2021-11-05 4:35 pm |
N/A 2031-11-03 |
PROGENITY INC. | PROG | Howe Jill Ann Director |
159,633 | $0 | 159,633 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:03 pm |
N/A N/A |
PROGENITY INC. | PROG | NEUMANN CLARKE See Remarks |
2,336 | $1.66 | 134,250 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:03 pm |
N/A N/A |
PROGENITY INC. | PROG | Silvestry Damon See Remarks |
1,478 | $1.66 | 289,178 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:03 pm |
N/A N/A |
PROGENITY INC. | PROG | Stylli Harry Chairman & CEO 10% Owner |
10,335 | $1.66 | 14,816,522 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:01 pm |
N/A N/A |
PROGENITY INC. | PROG | Hashemi Hutan Chief Compliance Officer |
158 | $1.66 | 22,440 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:00 pm |
N/A N/A |
PROGENITY INC. | PROG | dEsparbes Eric Chief Financial Officer |
5,718 | $1.66 | 196,397 (Direct) |
View |
2021-08-15 Tax Withholding |
2021-08-17 4:00 pm |
N/A N/A |
PROGENITY INC. | PROG | Cooper Matthew T Chief Scientific Officer |
560 | $1.66 | 127,852 (Direct) |
View |
2021-08-06 Tax Withholding |
2021-08-09 9:19 pm |
N/A N/A |
PROGENITY INC. | PROG | Seelye Troy Chief Information Officer |
23,673 | $1.94 | 59,756 (Direct) |
View |
2021-07-01 Option Award |
2021-07-06 6:34 pm |
N/A 2031-07-01 |
PROGENITY INC. | PROG | Sarna Surbhi Director |
156,593 | $0 | 156,593 (Direct) |
View |
2021-06-14 Option Award |
2021-06-16 6:07 pm |
N/A 2021-06-14 |
PROGENITY INC. | PROG | Powell Lynne Director |
80,907 | $0 | 99,242 (Direct) |
View |
2021-06-14 Option Award |
2021-06-16 6:06 pm |
N/A 2031-06-14 |
PROGENITY INC. | PROG | NUSSBAUM SAMUEL R MD Director |
80,907 | $0 | 99,242 (Direct) |
View |
2021-06-14 Option Award |
2021-06-16 6:03 pm |
N/A 2031-06-14 |
PROGENITY INC. | PROG | Kotzin Brian L. Director |
80,907 | $0 | 99,242 (Direct) |
View |